Dean E. Miller
Dean joined Novitas Capital in 1998, and is focused on Life Sciences investments. He has over 18 years of experience working for and with both large and small companies. Dean is currently on the Board of Directors of Cellumen and VIPdesk, and is an observer to the Board of Directors of Agile Therapeutics, GelMed Sciences, Logical Therapeutics, and Neuronyx. He has led investments in and served as director or observer of Renal Solutions (acquired by Fresenius (NYSE: FMS)), Incurrent Solutions (acquired by Online Resources (NASDAQ: ORCC)) and LearnNow, Inc. (acquired by Edison Schools).